Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 45 Breast Neoplasms 20 Myelodysplastic Syndromes 19 Prostatic Neoplasms 12 Neoplasms 12 Leukemia, Myelomonocytic, Chronic 12 Carcinoma, Hepatocellular 10 Stomach Neoplasms 9 Recurrence 9 Carcinoma, Non-Small-Cell Lung 8 Neoplasm Metastasis 7 Esophageal Neoplasms 7 Uterine Cervical Neoplasms 6 Sarcoma 6 Ovarian Neoplasms 6 Multiple Myeloma 6 Lung Neoplasms 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Myeloproliferative Disorders 5 Melanoma 5 Lymphoma, Non-Hodgkin 5 Lymphoma, B-Cell 5 Esophageal Squamous Cell Carcinoma 5 Colorectal Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Pancreatic Neoplasms 4 Myelodysplastic-Myeloproliferative Diseases 4 Leukemia, Biphenotypic, Acute 4 Cholangiocarcinoma 4 Thrombocythemia, Essential 3

Interventions

Parenteral Nutrition 9 fish oil triglycerides 2 soybean oil, phospholipid emulsion 1 alanylglutamine 1 SMOFlipid 1 Radiotherapy 1 Parenteral Nutrition, Total 1 Parenteral Nutrition, Home 1 Parenteral Nutrition Solutions 1 Nutrition Assessment 1 Insulin Glargine 1 Insulin 1 Injections 1 Glucose 1 Enteral Nutrition 1 Emulsions 1 Dietary Supplements 1 DNA, Ribosomal 1 Clinical Trials as Topic 1 ClinOleic 1 Cisplatin 1 Cetuximab 1 Amino Acids 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hyperphagia × Injections × Clear all

NCT02216799 2016-02-25

GLUCOSE-in-PN

King Faisal Specialist Hospital & Research Center

Phase 4 Completed

Hyperglycemia, Hyperphagia, Insulin Resistance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡